FeesSafety
Pluang+

Doximity faces class action lawsuit over alleged misleading revenue growth claims and market share losses.

Market News
17 Sep 2026
PRNewsWire
View Source
Bearish
Doximity faces class action lawsuit over alleged misleading revenue growth claims and market share losses.

Doximity, a digital platform for medical professionals, is subject to a class action lawsuit alleging it made false or misleading statements about its revenue growth and market position. The lawsuit claims Doximity overstated the impact of its Newsfeed on revenue and lost market share to competitors with better pricing and engagement strategies. Stock price drops followed announcements of cautious ad spending outlooks, lowered revenue guidance, and missed revenue targets between 2025 and 2026. Investors who bought Doximity stock between August 2024 and May 2026 can seek lead plaintiff status in the case by November 16, 2026.

The Doximity class action lawsuit is the subject of this update, provided here with Pluang's Health sector market data as of Sep 18, 2026 03:42 WIB. Among 91 priced Health-sector US stocks on Pluang, 60 advanced while 30 declined. Notably, Illumina, Inc. (ILMN) and Enveric Biosciences Inc (ENVB) both rose by 6.71%, with ILMN seeing 100% buy orders and a typical hold time of 86 days, contrasting with ENVB's shorter 12-day hold time and 60% buy orders. Sana Biotechnology Inc (SANA) also gained 6.34%, supported by 71% buy orders and a 22-day typical hold time.

More News

Darolutamide with ADT and radiation cuts metastasis or death risk by 58% in high-risk prostate cancer patients.

Darolutamide with ADT and radiation cuts metastasis or death risk by 58% in high-risk prostate cancer patients.

Interim results from the Phase 3 DASL-HiCaP trial show that adding darolutamide to standard androgen deprivation therapy (ADT) and radiation therapy reduces the risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence...

Company Fundamentals
Bullish
2 hours ago
Anthropic's revenue jumps to $16.3B in H1 2026, up from $1.1B last year

Anthropic's revenue jumps to $16.3B in H1 2026, up from $1.1B last year

Anthropic reported a massive increase in revenue, reaching $16.3 billion in the first half of 2026 compared to just $1.1 billion in the same period last year. This surge highlights rapid growth and strong demand for its products or services. The dram...

Market News
Bullish
3 hours ago
Tower Semiconductor's growth driven by Silicon Photonics with strong 2027 contracts and Q2 2026 beat.

Tower Semiconductor's growth driven by Silicon Photonics with strong 2027 contracts and Q2 2026 beat.

Tower Semiconductor is entering a new growth phase fueled by Silicon Photonics, securing $1.3 billion in contracts for 2027 and $290 million in pre-payments. In Q2 2026, the company reported revenue of $460 million, a 23.7% increase year-over-year, w...

Analyst Insights
Bullish
4 hours ago
Bitget hacker moves $19.48M in Bitcoin amid ongoing fund tracking after $387.5M breach

Bitget hacker moves $19.48M in Bitcoin amid ongoing fund tracking after $387.5M breach

The Bitget hacker has transferred $19.48 million, mostly in Bitcoin, across 52 transactions as tracked by blockchain intelligence firm Arkham. Since October 15, a total of $78.01 million has moved to new addresses linked to the September breach, whic...

Market News
Bearish
4 hours ago
XRP could see gains in next 9 months, linked to U.S. midterm election patterns and rising ETF inflows.

XRP could see gains in next 9 months, linked to U.S. midterm election patterns and rising ETF inflows.

A crypto commentator highlighted that historically, 92% of nine-month periods after U.S. midterm elections have seen market gains, averaging 19%, with the only negative period during the Great Depression. This pattern suggests potential positive mome...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App